Najat Khan

CEO and President, Director, Recursion Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.8M

Companies

Latest trade

Sep 8, 2026

Companies

Recursion Pharmaceuticals, Inc.CEO and President, Director −$0.8M

Trades

RXRX Sold 22,408 shares at $3.52 · planned $0.1M Sep 8

RXRX Sold 23,588 shares at $3.58 · planned $0.1M Jun 5

RXRX Sold 28,298 shares at $3.35 · planned $0.1M Mar 9

RXRX Sold 124,403 shares at $4.41 · planned $0.5M Dec 22

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.